Nektar Therapeutics (NKTR): EPS (Diluted)
-$9.73
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$9.73 | n/m | 2026-03-13, From 2025-01-01 |
| 2024-12-31 | -$8.68 | n/c | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | -$1.45 | n/m | 2025-03-14, From 2023-01-01 |
| 2022-12-31 | -$1.97 | n/m | 2024-03-05, From 2022-01-01 |
| 2021-12-31 | -$2.86 | n/m | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | -$2.49 | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$2.52 | n/m | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $3.78 | n/m | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | -$0.62 | n/m | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | -$1.10 | n/a | 2019-03-01, From 2016-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Nektar Therapeutics (NKTR) | 2025-12-31 | -$9.73 | n/m |
| Agios Pharmaceuticals, Inc. (AGIO) | 2025-12-31 | -$7.12 | n/m |
| Q32 Bio Inc. (QTTB) | 2025-12-31 | $2.42 | n/m |
| Ocular Therapeutix, Inc (OCUL) | 2025-12-31 | -$1.42 | n/m |
| Journey Medical Corp (DERM) | 2025-12-31 | -$0.47 | n/m |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2025-12-31 | -$0.14 | n/m |
| Tango Therapeutics, Inc. (TNGX) | 2025-12-31 | -$0.87 | n/m |
| Nuvation Bio Inc. (NUVB) | 2025-12-31 | -$0.60 | n/m |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | -$0.75 | n/m |
Compare NKTR, AGIO, QTTB, OCUL side by side · Screen every company in Pharmaceutical Preparations ↗